Black Diamond Therapeutics (BDTX) 2025 Conference June 04, 2025 04:20 PM ET Speaker0 Good afternoon. My name is Farzin Hak, one of the biotech analysts at Jefferies. I'm happy to introduce Mark Vileka, CEO of, Black Diamond Therapeutics. This is a fireside chat format. Thank you for joining us today. Speaker1 Thanks Farzan. Pleasure to be here. Speaker0 For those who are new to the story, can you provide a short overview of your program? Speaker1 Sure. So Black Diamond is a precision small molecule oncology ...